Indeed, certain studies have demonstrated that the co-existence of WT-FLT3 attenuated the anti-tumor effects of FLT3 inhibitors on FLT3-mutated AML cells in vitro and in vivo [88,90,91]. Here, FLT3 is linked to neoplasm.